These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 25505279

  • 1. Chronic lymphocytic leukemia cells express CD38 in response to Th1 cell-derived IFN-γ by a T-bet-dependent mechanism.
    Bürgler S, Gimeno A, Parente-Ribes A, Wang D, Os A, Devereux S, Jebsen P, Bogen B, Tjønnfjord GE, Munthe LA.
    J Immunol; 2015 Jan 15; 194(2):827-35. PubMed ID: 25505279
    [Abstract] [Full Text] [Related]

  • 2. Investigating the role of CD38 and functionally related molecular risk factors in the CLL NOD/SCID xenograft model.
    Aydin S, Grabellus F, Eisele L, Möllmann M, Hanoun M, Ebeling P, Moritz T, Carpinteiro A, Nückel H, Sak A, Göthert JR, Dührsen U, Dürig J.
    Eur J Haematol; 2011 Jul 15; 87(1):10-9. PubMed ID: 21692849
    [Abstract] [Full Text] [Related]

  • 3. Expression levels of CD38 on leukemic B cells but not on non-leukemic T cells are comparably stable over time and predict the course of disease in patients with chronic lymphocytic leukemia.
    Eisele L, Haddad T, Sellmann L, Dührsen U, Dürig J.
    Leuk Res; 2009 Jun 15; 33(6):775-8. PubMed ID: 18922578
    [Abstract] [Full Text] [Related]

  • 4. Chronic lymphocytic leukemia cell CD38 expression and inducible nitric oxide synthase expression are associated with serum IL-4 levels.
    Levesque MC, Chen Y, Beasley BE, O'Loughlin CW, Gockerman JP, Moore JO, Weinberg JB.
    Leuk Res; 2006 Jan 15; 30(1):24-8. PubMed ID: 16039714
    [Abstract] [Full Text] [Related]

  • 5. Chronic lymphocytic leukemia cells are activated and proliferate in response to specific T helper cells.
    Os A, Bürgler S, Ribes AP, Funderud A, Wang D, Thompson KM, Tjønnfjord GE, Bogen B, Munthe LA.
    Cell Rep; 2013 Aug 15; 4(3):566-77. PubMed ID: 23933259
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival.
    Zucchetto A, Benedetti D, Tripodo C, Bomben R, Dal Bo M, Marconi D, Bossi F, Lorenzon D, Degan M, Rossi FM, Rossi D, Bulian P, Franco V, Del Poeta G, Deaglio S, Gaidano G, Tedesco F, Malavasi F, Gattei V.
    Cancer Res; 2009 May 01; 69(9):4001-9. PubMed ID: 19383907
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. CD38 expression levels in chronic lymphocytic leukemia B cells are associated with activation marker expression and differential responses to interferon stimulation.
    Pittner BT, Shanafelt TD, Kay NE, Jelinek DF.
    Leukemia; 2005 Dec 01; 19(12):2264-72. PubMed ID: 16208411
    [Abstract] [Full Text] [Related]

  • 10. Clinical relevance of the expression of the CD31 ligand for CD38 in patients with B-cell chronic lymphocytic leukemia.
    Ibrahim S, Jilani I, O'Brien S, Rogers A, Manshouri T, Giles F, Faderl S, Thomas D, Kantarjian H, Keating M, Albitar M.
    Cancer; 2003 Apr 15; 97(8):1914-9. PubMed ID: 12673718
    [Abstract] [Full Text] [Related]

  • 11. ATM, CTLA4, MNDA, and HEM1 in high versus low CD38 expressing B-cell chronic lymphocytic leukemia.
    Joshi AD, Hegde GV, Dickinson JD, Mittal AK, Lynch JC, Eudy JD, Armitage JO, Bierman PJ, Bociek RG, Devetten MP, Vose JM, Joshi SS.
    Clin Cancer Res; 2007 Sep 15; 13(18 Pt 1):5295-304. PubMed ID: 17875758
    [Abstract] [Full Text] [Related]

  • 12. Immunophenotypic features distinguishing familial chronic lymphocytic leukemia from sporadic chronic lymphocytic leukemia.
    Ahmad E, Steinberg SM, Goldin L, Hess CJ, Caporaso N, Kreitman RJ, Wiestner A, Wilson W, White T, Marti G, Stetler-Stevenson M.
    Cytometry B Clin Cytom; 2008 Jul 15; 74(4):221-6. PubMed ID: 18431797
    [Abstract] [Full Text] [Related]

  • 13. Immunoregulatory effects of sinomenine on the T-bet/GATA-3 ratio and Th1/Th2 cytokine balance in the treatment of mesangial proliferative nephritis.
    Cheng Y, Zhang J, Hou W, Wang D, Li F, Zhang Y, Yuan F.
    Int Immunopharmacol; 2009 Jul 15; 9(7-8):894-9. PubMed ID: 19336263
    [Abstract] [Full Text] [Related]

  • 14. Immunophenotypic characterization of the leukemic B-cells from Iranian patients with chronic lymphocytic leukemia: association between CD38 expression and disease progression.
    Hojjat Farsangi M, Jeddi-Tehrani M, Razavi SM, Sharifian RA, Shamsian Khoramabadi A, Rabbani H, Shokri F.
    Iran J Immunol; 2008 Mar 15; 5(1):25-35. PubMed ID: 18319522
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. E2A is a transcriptional regulator of CD38 expression in chronic lymphocytic leukemia.
    Saborit-Villarroya I, Vaisitti T, Rossi D, D'Arena G, Gaidano G, Malavasi F, Deaglio S.
    Leukemia; 2011 Mar 15; 25(3):479-88. PubMed ID: 21212793
    [Abstract] [Full Text] [Related]

  • 18. Effect of treatment of rheumatoid arthritis with infliximab on IFN gamma, IL4, T-bet, and GATA-3 expression: link with improvement of systemic inflammation and disease activity.
    Kawashima M, Miossec P.
    Ann Rheum Dis; 2005 Mar 15; 64(3):415-8. PubMed ID: 15286007
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Chromosome aberrations evaluated by comparative genomic hybridization in B-cell chronic lymphocytic leukemia: correlation with CD38 expression.
    Ottaggio L, Viaggi S, Zunino A, Zupo S, Rossi E, Spriano M, Abbondandolo A, Ferrarini M.
    Haematologica; 2003 Jul 15; 88(7):769-77. PubMed ID: 12857555
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.